Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review

Clinical pharmacists may contribute to several stages of sepsis management, although interventions and reported outcomes vary across clinical settings. This scoping review aimed to map clinical pharmacist interventions among adults with suspected or confirmed sepsis or septic shock receiving hospital-based acute care and to characterize associated process, stewardship, medication-safety, and clinical outcomes. Guided by Joanna Briggs Institute methodology and the PRISMA extension for scoping reviews, we searched PubMed/MEDLINE, ScienceDirect, and Google Scholar in March 2026 for English- or Spanish-language publications from 2016 through 2025. The search identified 1,482 records; 1,306 were screened, and 235 reports underwent full-text assessment. The final synthesis included eight primary studies and one systematic review, interpreted separately because of overlapping primary evidence. Interventions encompassed early antimicrobial review, participation in sepsis response teams, protocol-guided treatment decisions, antimicrobial optimization, and structured medication review. Across the primary studies, favorable findings were reported for antimicrobial appropriateness and selected measures of treatment timeliness. Some studies also reported favorable antimicrobial stewardship and medication-safety outcomes, although adverse drug reactions and drug-related problems represented distinct measures. No statistically significant improvement in mortality or length of stay was demonstrated in the comparative studies assessing these outcomes. The findings suggest that clinical pharmacist involvement may improve selected aspects of pharmacotherapeutic care in sepsis, but differences in intervention models, study designs, and outcome definitions limit causal interpretation and generalizability. Future multicenter studies should evaluate clearly defined pharmacist roles, appropriate comparators, and patient-centered outcomes.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2026-11-16
DOI
https://doi.org/10.7759/cureus.119740
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review

Esteban Zavaleta‐Monestel, José Pablo Díaz‐Madriz, José Andrés Castro Gamboa, Jeaustin Mora-Jiménez et al.
2 links
Cureus
Sepsis Diagnosis and Treatment
article

Clinical Pharmacist Interventions in Adults With Sepsis and Septic Shock: A Scoping Review

Esteban Zavaleta‐Monestel, José Pablo Díaz‐Madriz, José Andrés Castro Gamboa, Jeaustin Mora-Jiménez, Kimberly R Torres-Mora
article en

Abstract

Clinical pharmacists may contribute to several stages of sepsis management, although interventions and reported outcomes vary across clinical settings. This scoping review aimed to map clinical pharmacist interventions among adults with suspected or confirmed sepsis or septic shock receiving hospital-based acute care and to characterize associated process, stewardship, medication-safety, and clinical outcomes. Guided by Joanna Briggs Institute methodology and the PRISMA extension for scoping reviews, we searched PubMed/MEDLINE, ScienceDirect, and Google Scholar in March 2026 for English- or Spanish-language publications from 2016 through 2025. The search identified 1,482 records; 1,306 were screened, and 235 reports underwent full-text assessment. The final synthesis included eight primary studies and one systematic review, interpreted separately because of overlapping primary evidence. Interventions encompassed early antimicrobial review, participation in sepsis response teams, protocol-guided treatment decisions, antimicrobial optimization, and structured medication review. Across the primary studies, favorable findings were reported for antimicrobial appropriateness and selected measures of treatment timeliness. Some studies also reported favorable antimicrobial stewardship and medication-safety outcomes, although adverse drug reactions and drug-related problems represented distinct measures. No statistically significant improvement in mortality or length of stay was demonstrated in the comparative studies assessing these outcomes. The findings suggest that clinical pharmacist involvement may improve selected aspects of pharmacotherapeutic care in sepsis, but differences in intervention models, study designs, and outcome definitions limit causal interpretation and generalizability. Future multicenter studies should evaluate clearly defined pharmacist roles, appropriate comparators, and patient-centered outcomes.

Cureus
Universidad de Ciencias Medicas (CR), Universidad Bíblica Latinoamericana (CR)
Good health and well-being
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon